Zobrazeno 1 - 10 of 102 pro vyhledávání: '"Rawson, TM"'
1
Akademický článek
Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations
Autor: Rawson TM, Antcliffe DB, Wilson RC, Abdolrasouli A, Moore LSP
Publikováno v: Infection and Drug Resistance, Vol Volume 16, Pp 2709-2726 (2023)
Timothy M Rawson,1– 3 David B Antcliffe,2,4 Richard C Wilson,1– 3 Alireza Abdolrasouli,5 Luke SP Moore1,6,7 1Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Hammersmith Hospital, London, UK; 2Cent
Externí odkaz: https://doaj.org/article/95ac32d334eb46f2b0ad2d7ff2af139c
Zobrazit plný text záznamu
2
Can precision antibiotic prescribing help prevent the spread of carbapenem-resistant organisms in the hospital setting?
Autor: Vasikasin, V, Rawson, TM, Holmes, AH, Otter, J
Publikováno v: JAC-Antimicrobial Resistance. 5
The emergence of carbapenem-resistant organisms (CROs) is a significant global threat. Reduction of carbapenem consumption can decrease CROs. In the global endemic era of ESBL-producing bacteria, carbapenems are considered the treatment of choice, le
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::226065ecf0543376aae9688a18c6e46e
https://doi.org/10.1093/jacamr/dlad036
Zobrazit plný text záznamu
3
Forecasting implementation, adoption, and evaluation challenges for an electronic game–based antimicrobial stewardship intervention: co-design workshop with multidisciplinary stakeholders (Preprint)
Autor: Castro-Sánchez, E, Sood, A, Rawson, TM, Firth, J, Holmes, AH
Background: Serious games have been proposed to address the lack of engagement and sustainability traditionally affecting interventions aiming to improve optimal antibiotic use among hospital prescribers. Objective: The goal of the research was to fo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::5845951e14523d2c7046df4eb9c36a24
http://hdl.handle.net/10044/1/76352
Zobrazit plný text záznamu
4
Development of a web-based tool for undergraduate engagement in medical research; the ProjectPal experience
Autor: Rawson, TM, Sivakumaran, P, Lobo, R, Mahir, G, Rossiter, A, Levy, J, McGregor, AH, Lupton, M, Easton, G, Gill, D
Publikováno v: BMC Medical Education, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Medical Education
Background We report the development and evaluation of a web-based tool designed to facilitate student extra-curricular engagement in medical research through project matching students with academic supervisors. UK based university students were surv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5c15fc891263cb3b36452a9e06403a67
http://hdl.handle.net/10044/1/61928
Zobrazit plný text záznamu
5
Closed-loop control for precision antimicrobial delivery: an In silico proof-of-concept
Autor: Herrero, P, Rawson, TM, Philip, A, Moore, LSP, Holmes, AH, Georgiou, P
IEEE Objective: Inappropriate dosing of patients with antibiotics is a driver of antimicrobial resistance, toxicity, and poor outcomes of therapy. In this paper, we investigate, in silico, the hypothesis that the use of a closed-loop control system c
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::d2132e685c928a0b2f9647cb1bf5ae90
http://hdl.handle.net/10044/1/56020
Zobrazit plný text záznamu
6
Akademický článek
Assessing the role of peripheral CD8 T cells in neurocognitive impairment in HIV-infected men who have sex with men: data from the MSM Neurocog Study.
Autor: Rawson, TM, Dubb, S, Pozniak, A, Kelleher, WP, Mandalia, S, Gazzard, B, Barber, TJ
Publikováno v: International Journal of STD & AIDS; Feb2015, Vol. 26 Issue 2, p128-132, 5p, 2 Charts
Zobrazit plný text záznamu
7
Akademický článek
Using digital health technologies to optimise antimicrobial use globally.
Autor: Rawson TM; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK. Electronic address: timothy.rawson07@imperial.ac.uk., Zhu N; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Galiwango R; The African Centre of Excellence in Bioinformatics and Data Intensive Sciences, The Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda., Cocker D; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Islam MS; Child Health Research Foundation, Dhaka, Bangladesh., Myall A; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Centre for Mathematics of Precision Healthcare, Imperial College London, London, UK., Vasikasin V; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; Division of Infectious Diseases, Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand., Wilson R; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK., Shafiq N; Clinical Pharmacology Unit, Department of Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Das S; Antimicrobial Pharmacodynamics and Therapeutics, Department of Pharmacology, The University of Liverpool, Liverpool Health Partners, Liverpool, UK., Holmes AH; Centre for Antimicrobial Optimisation, Imperial College London, London, UK; Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK; The David Price Evans Global Health & Infectious Diseases Group, The University of Liverpool, Liverpool, UK.
Publikováno v: The Lancet. Digital health [Lancet Digit Health] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.
Zobrazit plný text záznamu
8
Akademický článek
Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Voriconazole for Predicting the Clinical Outcomes of Adult Patients with Invasive Aspergillosis.
Autor: Duangpraphat M; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand., Wilson RC; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, United Kingdom., Rawson TM; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and., Santimaleeworagun W; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand.; Department of Pharmaceutical Care, Faculty of Pharmacy, Silpakorn University, Nakorn Pathom, Thailand., Nasomsong W; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand., Holmes AH; Centre for Antimicrobial Optimisation, Imperial College London, United Kingdom.; David Price Evans Global Health and Infectious Diseases Research Group, University of Liverpool, United Kingdom.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and., Vasikasin V; Department of Internal Medicine, Phramongkutklao Hospital and College of Medicine, Ratchadhevi, Bangkok, Thailand.; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Hospital, London, United Kingdom; and.
Publikováno v: Therapeutic drug monitoring [Ther Drug Monit] 2024 Oct 22. Date of Electronic Publication: 2024 Oct 22.
Zobrazit plný text záznamu
9
Akademický článek
Innovative approaches in phenotypic beta-lactamase detection for personalised infection management.
Autor: Lawrence J; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom. j.lawrence21@imperial.ac.uk.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom. j.lawrence21@imperial.ac.uk., O'Hare D; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.; Department of Bioengineering, Imperial College London, South Kensington Campus, London, United Kingdom., van Batenburg-Sherwood J; Department of Bioengineering, Sir Michael Uren Hub, Imperial College London, White City Campus, London, United Kingdom., Sutton M; Antimicrobial Discovery, Development and Diagnostics (AD3) UK Health Security Agency, Porton Down, Salisbury, Wiltshire, United Kingdom.; Institute of Pharmaceutical Science, King's College London, London, United Kingdom., Holmes A; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.; David Price Evans Infectious Diseases and Global Health Group, University of Liverpool, Liverpool, United Kingdom., Rawson TM; The NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, Hammersmith Campus, London, United Kingdom.; Centre for Antimicrobial Optimisation, Imperial College London, London, United Kingdom.
Publikováno v: Nature communications [Nat Commun] 2024 Oct 21; Vol. 15 (1), pp. 9070. Date of Electronic Publication: 2024 Oct 21.
Zobrazit plný text záznamu
10
Akademický článek
Exploring real-world vancomycin target attainment in neonatal intensive care in the context of Staphylococcal infections: a retrospective observational cohort study.
Autor: Blank M; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom. Electronic address: michael.blank@nhs.net., Wilson RC; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom., Wan Y; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Peters J; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom., Davies F; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom., Tyszczuk L; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom., Pichon B; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Riezk A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom., Demirjian A; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom; Department of Paediatric Infectious Disease & Immunology, Evelina London Children's Hospital, London, UK; Faculty of Life Sciences & Medicine, Kings College London, London, UK; Faculty of Medicine, Imperial College London, London, UK., Brown CS; Healthcare-Associated Infection (HCAI), Fungal, Antimicrobial Resistance (AMR), Antimicrobial Use (AMU) & Sepsis Division, UK Health Security Agency (UKHSA), 61 Colindale Avenue London NW9 5EQ, United Kingdom., Gilchrist M; Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS. United Kingdom; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom., Holmes AH; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom., Rawson TM; National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Department for Infectious Disease, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN. United Kingdom; Centre for Antimicrobial Optimisation, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, United Kingdom; David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool L7 8TX, United Kingdom.
Publikováno v: The Journal of infection [J Infect] 2024 Aug; Vol. 89 (2), pp. 106191. Date of Electronic Publication: 2024 Jun 05.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje